Containment of Highly Potent API's
Date: | 01-Apr-14 to 01-Apr-14 |
Location: | Holiday Inn, Bloomsbury / London / United Kingdom |
Category: | Chemicals Healthcare & Pharmaceuticals Science Conferences & Trade Fairs |
SMi’s Containment of Highly Potent API's masterclass - hosted by Safebridge & ILC Dover LP will take place on the 1st April in London
Growth in the market of High Potency APIs is considered to be the single largest and important trend that deserves attention by all players in this field. All highly potent APIs must be produced under conditions that protect any API substances from contamination and the inadvertent carryover of a different product being previously or simultaneously manufactured. To accomplish this task, there is a continued need to focus on the development of production and handling methods that will be either single-use systems and/or new technologies. The focus is on the improvement upon today’s product protection of the API from cross contamination from other HPAPI produced at the facility or site.
(Source: totalbiopharma.com, The single largest trend in the HPAPI space, 2014)
Five years ago the drivers for containment were almost strictly for protecting the operators for exposure of the compound. Since then, containing the product to minimise the risk cross contamination in the facility has become equally important. SMi's masterclass hosted by SafeBridge & ILC Dover LP will assess how to improve understanding on containment and identifying how to minimise the risks of exposure.
Key benefits to this masterclass are:
• Gain an accurate understanding of pharmaceutical compound hazards
• Evaluate flexible vs. hard wall containment
• Review practical case studies using different containment methods to create
standardisation
• Assess facility design elements to ensure confidence in meeting containment objectives
Growth in the market of High Potency APIs is considered to be the single largest and important trend that deserves attention by all players in this field. All highly potent APIs must be produced under conditions that protect any API substances from contamination and the inadvertent carryover of a different product being previously or simultaneously manufactured. To accomplish this task, there is a continued need to focus on the development of production and handling methods that will be either single-use systems and/or new technologies. The focus is on the improvement upon today’s product protection of the API from cross contamination from other HPAPI produced at the facility or site.
(Source: totalbiopharma.com, The single largest trend in the HPAPI space, 2014)
Five years ago the drivers for containment were almost strictly for protecting the operators for exposure of the compound. Since then, containing the product to minimise the risk cross contamination in the facility has become equally important. SMi's masterclass hosted by SafeBridge & ILC Dover LP will assess how to improve understanding on containment and identifying how to minimise the risks of exposure.
Key benefits to this masterclass are:
• Gain an accurate understanding of pharmaceutical compound hazards
• Evaluate flexible vs. hard wall containment
• Review practical case studies using different containment methods to create
standardisation
• Assess facility design elements to ensure confidence in meeting containment objectives
Visitors
Who Should Attend
• Environmental H&S managers
• Directors
• Project Managers
• Engineers
• Industrial hygienists
• Quality managers
• Environmental H&S managers
• Directors
• Project Managers
• Engineers
• Industrial hygienists
• Quality managers
Exhibitors
Who Should Attend
• Environmental H&S managers
• Directors
• Project Managers
• Engineers
• Industrial hygienists
• Quality managers
• Environmental H&S managers
• Directors
• Project Managers
• Engineers
• Industrial hygienists
• Quality managers
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- CNES News Today
- Canadian Space Agency News Today
- Chemical Industry Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- JAXA News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- NASA News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- Research Reports News Today
- SARS News Today
- Science News Today
- Wellness News Today